Online HIV/AIDS Continuing Medical Education

Earn CME credit at your leisure and stay abreast of HIV/AIDS clinical updates.We deliver high-quality continuing medical educational activities developed by clinicians and leading researchers in the field of HIV/AIDS. Our CME activities are all free and can be taken at any time from any Internet-connected computer.

Course Catalog

HIV/AIDS Confidentiality Law Overview

This on-line training provides information about New York State's HIV Confidentiality Law (Public Health Law - Article 27-F) and is designed to meet provider requirements for initial training on confidentiality. This is not a CME course.

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. State the basic requirements of the New York State HIV confidentiality law
  2. List the main exceptions to the HIV confidentiality law’s non-disclosure rule
  3. Complete an HIV release form
  4. Describe the legal consequences for violating the HIV confidentiality law

 

Street drugs & HIV

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Describe the interaction of substance use HIV and HIV medications
  2. Be familiar with documented risks of substance use
  3. Understand effects of Marijuana & Benozodiazepines
  4. Understand possible treatment interventions

 

PRNHIV Viral Load: New Opportunities & Advances in Technology

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Understand the clinical significance of low-level viremia.
  2. Understand the role of Community Viral Load in HIV care.
  3. Understand the role of HIV treatment and undetectable viral load as prevention tools.
  4. Recognize advances in viral load technologies that support contemporary HIV treatment.

 

PRNToward a Cure for HIV: Are We There Yet

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Understand the evolution of HIV reservoir research
  2. Explain the impact of antiretroviral therapy on HIV reservoirs
  3. Discuss the mechanisms of HIV persistence in infected individuals receiving antiretroviral therapy
  4. Examine the feasibility of eradication of HIV in infected individuals receiving antiretroviral therapy

 

PRNUnraveling the Genetic Basis of HIV Control

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Better appreciate the use of genome-wide association scans to understand human disease
  2. Describe the genetic basis for control and lack of control of HIV
  3. Discuss the implications of genetic studies for vaccine design
  4. Understand the effects of immune selection pressure on viral fitness

 

PRNCurrent Controversies in Antiretroviral Therapy

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Be aware of newer antiretroviral agents.
  2. Discuss the latest data on strategies for starting antiretroviral therapy and what to start with.
  3. Discuss the latest data on when to change antiretroviral therapy and what to change to.

 

PRNAntiretroviral Chemoprophylaxis

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Understand how oral antiretroviral agents may be used for pre- and post-exposure prophylaxis.
  2. Understand how topical antiretroviral agents may be used as microbicides to prevent HIV transmission.
  3. Understand the recent results of the CAPRISA 004 and iPrEx efficacy trials, and learn about upcoming chemoprophylaxis trials, and when their results will be known.
  4. Learn about the possibility of using novel antiretroviral agents for chemoprophylaxis.

 

PRNNew Drugs and New Strategies in the Treatment of HIV Disease

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Review data on drugs in phase 3 of development for the treatment of HIV disease.
  2. Describe new strategies for combining antiretroviral agents.
  3. Discuss data on 2-drug combinations and induction/maintenance in the treatment of HIV disease.

 

HIV and Sexually Transmitted Infections

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Describe the epidemiologic associations between HIV and other sexually transmitted infections (STIs)
  2. Describe the clinical manifestations of syphilis and how they may be altered in the setting of co-infection with HIV
  3. Describe the clinical manifestations of gonorrhea and chlamydia

 

Preconception and Prenatal Care for the HIV Positive Woman

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Describe HIV epidemiology in HIV Mother to Child Transmission (MTCT)
  2. Describe key components of preconception care
  3. Review HIV care during pregnancy and post partum
  4. Recognize the symptoms of acute HIV
  5. Discuss the importance of continuity of care for the pregnant woman with HIV

 

Identifying Adherence Barriers and Drug-Drug Interactions

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Describe potential adherence barriers to antiretroviral therapy
  2. Identify strategies to overcome those barriers
  3. Describe adverse effects related to antiretroviral medications
  4. Identify strategies to manage those adverse effects
  5. Describe common mechanisms of ARV drug-drug interactions
  6. Identify medications that interact, or potentially interact, with ARVs

PRNVitamin D Deficiency in the HIV-infected Patient

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Describe the action of vitamin D and the potential consequences of vitamin D deficiency.
  2. Define the factors associated with abnormal vitamin D metabolism in the HIV-infected patient.
  3. Discuss current recommendations for screening & treatment of vitamin D deficiency in HIV-infected patients.

Prevention With Positives: Young MSM

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Epidemiologic Overview of HIV Incidence
  2. What's Behind the Increased Incidence in YMSM?
  3. Prevention Interventions That Have Shown Promise
  4. How Do We Train Providers to Focus on Prevention

Clinical Management of Alcohol Use & Abuse in HIV--Infected Patients

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Recognize the importance of alcohol screening for HIV infected patients.
  2. Identify at least three of the areas alcohol use/abuse impacts on clinical management of HIV.
  3. Define at-risk drinking, alcohol abuse, alcohol dependence, binge drinking and a "standard drink"
  4. State primary role, with regard to alcohol, of the clinician in the management of the patient who abuses/dependent on alcohol.

HIV Medication Errors

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Discuss background data on medication errors in the HIV infected population
  2. Review common types and causes of medication errors that occur in the HIV population
  3. Using patient cases, provide real life examples from the hospital and retail settings that describe HIV medication errors
  4. Provide strategies for preventing medication errors in the HIV infected population

HIV and Oral Health

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Describe the signs and symptoms of HIV infection
  2. Explain antiretroviral treatment for HIV infection.
  3. List pretreatment considerations for HIV/AIDS patients undergoing dental procedures.

 

Prevention For Positives and Negative

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. To understand the importance of discussing the prevention of HIV transmission with both HIV positive and HIV negative patients.
  2. To realize some factors that influence an individual's likelihood of transmitting or acquiring HIV.
  3. To recognize the rationale for making HIV testing a routine part of medical care, and how testing can be a means of prevention.
  4. To discuss ways to obtain a thorough and accurate sexual history/assessment.
  5. To gain increased knowledge of counseling and behavioral interventions that health care providers can use to help their patients with HIV related behavior change.

NYSDOH Immune Reconstitution Inflammatory Syndrome (IRIS) Guidelines: A Case Presentation

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Describe common characteristics of Immune Reconstitution Inflammatory Syndrome (IRIS)
  2. Outline the differential diagnosis of IRIS
  3. Discuss the management and the treatment of patients with IRIS

Overdose Prevention: The Role of Naloxone in the Community

Learning Objectives

At the completion of this educational session, participants should be able to:

  1. Discuss the epidemiology of opioid overdose
  2. Advise their patients on how to avoid, recognize and act on opioid overdoses
  3. Discuss the role and safety of prescribing and distributing naloxone in the community
  4. Understand the NYS requirements to become an Opioid Overdose Prevention Program

 

HIV and Oral Health

This free knowledge-based activity is designed for physicians, nurses, pharmacists, social workers, dentists, dental hygienists and other health care professionals in New Jersey who are involved in the care of persons with HIV/AIDS and/or hepatitis. This course is not sponsored by CEI, but may be of interested to those working with HIV patients.

Take the course